Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Social Stigma | 37 | 2024 | 788 | 8.350 |
Why?
|
Rural Population | 64 | 2024 | 2317 | 7.270 |
Why?
|
HIV Infections | 140 | 2024 | 17533 | 7.170 |
Why?
|
Uganda | 113 | 2024 | 1353 | 6.650 |
Why?
|
Depression | 43 | 2024 | 8237 | 3.440 |
Why?
|
Food Supply | 16 | 2021 | 544 | 2.500 |
Why?
|
Stereotyping | 9 | 2022 | 242 | 2.460 |
Why?
|
Mental Health | 26 | 2023 | 3278 | 2.300 |
Why?
|
Medication Adherence | 24 | 2024 | 2192 | 2.240 |
Why?
|
Anti-HIV Agents | 30 | 2022 | 4559 | 2.240 |
Why?
|
Police | 5 | 2024 | 158 | 2.070 |
Why?
|
Social Support | 14 | 2022 | 2192 | 2.030 |
Why?
|
Africa South of the Sahara | 19 | 2022 | 751 | 1.760 |
Why?
|
Violence | 7 | 2021 | 935 | 1.630 |
Why?
|
Anti-Retroviral Agents | 21 | 2022 | 1787 | 1.450 |
Why?
|
Law Enforcement | 2 | 2024 | 112 | 1.380 |
Why?
|
South Africa | 24 | 2024 | 1867 | 1.330 |
Why?
|
Epidemics | 5 | 2022 | 514 | 1.330 |
Why?
|
Cross-Sectional Studies | 67 | 2024 | 26318 | 1.330 |
Why?
|
Health Behavior | 7 | 2021 | 2650 | 1.280 |
Why?
|
Humans | 307 | 2025 | 765968 | 1.270 |
Why?
|
Adult | 154 | 2024 | 223044 | 1.250 |
Why?
|
Mortality | 5 | 2022 | 2904 | 1.250 |
Why?
|
Spouse Abuse | 5 | 2019 | 181 | 1.240 |
Why?
|
Homicide | 3 | 2021 | 293 | 1.240 |
Why?
|
Water Supply | 3 | 2024 | 204 | 1.230 |
Why?
|
Cause of Death | 6 | 2021 | 3708 | 1.220 |
Why?
|
Substance-Related Disorders | 9 | 2024 | 4416 | 1.220 |
Why?
|
HIV | 12 | 2023 | 1585 | 1.150 |
Why?
|
Female | 188 | 2025 | 396112 | 1.110 |
Why?
|
CD4 Lymphocyte Count | 13 | 2020 | 2587 | 1.100 |
Why?
|
Depressive Disorder | 7 | 2019 | 3714 | 1.090 |
Why?
|
HIV Seropositivity | 7 | 2021 | 961 | 1.070 |
Why?
|
Social Isolation | 3 | 2020 | 366 | 1.070 |
Why?
|
Stress, Psychological | 7 | 2021 | 4533 | 1.050 |
Why?
|
Fluoxetine | 3 | 2016 | 729 | 1.040 |
Why?
|
Population Surveillance | 8 | 2018 | 2590 | 1.030 |
Why?
|
Male | 166 | 2025 | 363698 | 1.030 |
Why?
|
Suicide | 7 | 2021 | 1604 | 1.020 |
Why?
|
Income | 6 | 2024 | 1874 | 1.010 |
Why?
|
Health Policy | 5 | 2021 | 2698 | 1.010 |
Why?
|
Rape | 5 | 2015 | 131 | 1.000 |
Why?
|
Crime Victims | 4 | 2015 | 348 | 0.990 |
Why?
|
Internal-External Control | 3 | 2017 | 347 | 0.990 |
Why?
|
Truth Disclosure | 7 | 2017 | 433 | 0.970 |
Why?
|
Rural Health | 9 | 2019 | 301 | 0.970 |
Why?
|
Social Problems | 2 | 2016 | 107 | 0.960 |
Why?
|
Health Status | 10 | 2017 | 4080 | 0.950 |
Why?
|
Depression, Postpartum | 3 | 2014 | 360 | 0.930 |
Why?
|
Young Adult | 60 | 2024 | 59889 | 0.930 |
Why?
|
Life Expectancy | 5 | 2022 | 1247 | 0.920 |
Why?
|
Sexually Transmitted Diseases | 6 | 2022 | 667 | 0.920 |
Why?
|
Socioeconomic Factors | 22 | 2024 | 7838 | 0.910 |
Why?
|
Anxiety | 8 | 2024 | 4671 | 0.910 |
Why?
|
Public Policy | 3 | 2021 | 551 | 0.910 |
Why?
|
Health Knowledge, Attitudes, Practice | 14 | 2024 | 4058 | 0.900 |
Why?
|
Condoms | 4 | 2017 | 336 | 0.890 |
Why?
|
Risk-Taking | 8 | 2022 | 1021 | 0.890 |
Why?
|
Insecticide-Treated Bednets | 3 | 2022 | 70 | 0.880 |
Why?
|
Family Characteristics | 7 | 2024 | 1001 | 0.880 |
Why?
|
Housing | 3 | 2020 | 683 | 0.880 |
Why?
|
Antiretroviral Therapy, Highly Active | 10 | 2021 | 1899 | 0.870 |
Why?
|
Drug Industry | 6 | 2009 | 791 | 0.870 |
Why?
|
Suicidal Ideation | 4 | 2021 | 1461 | 0.840 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 2019 | 2203 | 0.830 |
Why?
|
Sexual Behavior | 13 | 2022 | 2193 | 0.810 |
Why?
|
Counseling | 6 | 2021 | 1551 | 0.800 |
Why?
|
Circumcision, Male | 1 | 2023 | 148 | 0.790 |
Why?
|
Loneliness | 2 | 2024 | 211 | 0.790 |
Why?
|
Conflict of Interest | 4 | 2011 | 556 | 0.780 |
Why?
|
Alcohol Drinking | 5 | 2023 | 4040 | 0.780 |
Why?
|
Quinolones | 3 | 2011 | 387 | 0.770 |
Why?
|
Pandemics | 12 | 2023 | 8703 | 0.750 |
Why?
|
Viral Load | 16 | 2022 | 3386 | 0.730 |
Why?
|
Middle Aged | 92 | 2024 | 223009 | 0.720 |
Why?
|
United States | 48 | 2024 | 72903 | 0.720 |
Why?
|
HIV Integrase Inhibitors | 1 | 2022 | 164 | 0.700 |
Why?
|
Adolescent | 49 | 2024 | 88835 | 0.690 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2013 | 490 | 0.670 |
Why?
|
Automobiles | 1 | 2020 | 103 | 0.640 |
Why?
|
Health Personnel | 4 | 2024 | 3390 | 0.640 |
Why?
|
Qualitative Research | 14 | 2022 | 3139 | 0.640 |
Why?
|
Piperazines | 4 | 2011 | 2549 | 0.630 |
Why?
|
Psychiatry | 4 | 2016 | 1714 | 0.630 |
Why?
|
Mental Disorders | 9 | 2023 | 6853 | 0.610 |
Why?
|
Women | 3 | 2015 | 226 | 0.610 |
Why?
|
Health Surveys | 8 | 2020 | 4056 | 0.610 |
Why?
|
Prisons | 2 | 2021 | 178 | 0.580 |
Why?
|
Mass Screening | 5 | 2022 | 5446 | 0.580 |
Why?
|
Cost of Illness | 5 | 2022 | 1950 | 0.580 |
Why?
|
Analgesics, Opioid | 5 | 2021 | 3835 | 0.570 |
Why?
|
Antidepressive Agents | 5 | 2023 | 2897 | 0.570 |
Why?
|
Spouses | 1 | 2020 | 288 | 0.570 |
Why?
|
Wounds and Injuries | 5 | 2022 | 2511 | 0.570 |
Why?
|
Universities | 2 | 2021 | 998 | 0.570 |
Why?
|
Prevalence | 28 | 2024 | 15842 | 0.570 |
Why?
|
Emigration and Immigration | 2 | 2017 | 405 | 0.560 |
Why?
|
Policy Making | 2 | 2020 | 546 | 0.550 |
Why?
|
Information Dissemination | 3 | 2016 | 1142 | 0.550 |
Why?
|
Antipsychotic Agents | 4 | 2013 | 3076 | 0.550 |
Why?
|
Marital Status | 2 | 2015 | 426 | 0.550 |
Why?
|
Social Participation | 2 | 2016 | 187 | 0.550 |
Why?
|
Disease Transmission, Infectious | 2 | 2020 | 560 | 0.540 |
Why?
|
Agriculture | 2 | 2024 | 186 | 0.540 |
Why?
|
Regression Analysis | 9 | 2016 | 6322 | 0.540 |
Why?
|
Social Mobility | 1 | 2016 | 30 | 0.540 |
Why?
|
Health Plan Implementation | 1 | 2019 | 338 | 0.530 |
Why?
|
Stress Disorders, Post-Traumatic | 7 | 2024 | 4628 | 0.530 |
Why?
|
Disability Evaluation | 2 | 2022 | 1820 | 0.530 |
Why?
|
Politics | 2 | 2020 | 822 | 0.530 |
Why?
|
Adaptation, Psychological | 6 | 2022 | 2660 | 0.520 |
Why?
|
Pregnancy Complications | 3 | 2016 | 2975 | 0.520 |
Why?
|
Transportation | 3 | 2014 | 217 | 0.520 |
Why?
|
Prejudice | 2 | 2019 | 567 | 0.510 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 276 | 0.500 |
Why?
|
Patient Acceptance of Health Care | 6 | 2022 | 3230 | 0.500 |
Why?
|
Longitudinal Studies | 21 | 2024 | 14751 | 0.500 |
Why?
|
Self Report | 6 | 2021 | 3770 | 0.500 |
Why?
|
Health Promotion | 4 | 2021 | 2208 | 0.500 |
Why?
|
Opioid-Related Disorders | 2 | 2021 | 2178 | 0.500 |
Why?
|
Public Opinion | 1 | 2019 | 482 | 0.500 |
Why?
|
Bioethics | 2 | 2008 | 119 | 0.490 |
Why?
|
Work | 1 | 2016 | 195 | 0.490 |
Why?
|
Cannabis | 1 | 2021 | 446 | 0.490 |
Why?
|
Interpersonal Relations | 5 | 2015 | 1432 | 0.480 |
Why?
|
Postpartum Period | 4 | 2023 | 1205 | 0.480 |
Why?
|
Refugees | 5 | 2022 | 614 | 0.480 |
Why?
|
Depressive Disorder, Major | 4 | 2015 | 4808 | 0.480 |
Why?
|
Internship and Residency | 6 | 2015 | 5946 | 0.480 |
Why?
|
Disclosure | 4 | 2022 | 756 | 0.470 |
Why?
|
Evidence-Based Medicine | 5 | 2020 | 3685 | 0.470 |
Why?
|
Communicable Disease Control | 2 | 2023 | 856 | 0.470 |
Why?
|
Quality of Life | 13 | 2024 | 13462 | 0.470 |
Why?
|
Cluster Analysis | 3 | 2018 | 2721 | 0.470 |
Why?
|
September 11 Terrorist Attacks | 1 | 2015 | 107 | 0.470 |
Why?
|
Ethics, Research | 4 | 2025 | 178 | 0.470 |
Why?
|
Research Support as Topic | 3 | 2009 | 696 | 0.460 |
Why?
|
Perception | 3 | 2018 | 1205 | 0.460 |
Why?
|
Malaria | 3 | 2022 | 1246 | 0.460 |
Why?
|
Hospitals, Psychiatric | 1 | 2015 | 317 | 0.440 |
Why?
|
Age Distribution | 4 | 2021 | 2858 | 0.440 |
Why?
|
Mental Health Services | 4 | 2022 | 1723 | 0.430 |
Why?
|
Buprenorphine | 1 | 2021 | 665 | 0.430 |
Why?
|
Hepatitis C | 1 | 2023 | 1597 | 0.410 |
Why?
|
San Francisco | 4 | 2015 | 166 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.410 |
Why?
|
Parturition | 1 | 2017 | 454 | 0.410 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2014 | 226 | 0.410 |
Why?
|
Unsafe Sex | 1 | 2014 | 239 | 0.410 |
Why?
|
Pregnant Women | 3 | 2022 | 575 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.400 |
Why?
|
Cohort Studies | 30 | 2024 | 41649 | 0.400 |
Why?
|
Employment | 2 | 2020 | 1106 | 0.400 |
Why?
|
Prenatal Care | 3 | 2022 | 1160 | 0.400 |
Why?
|
Human Rights | 2 | 2012 | 312 | 0.390 |
Why?
|
Reproducibility of Results | 13 | 2022 | 20124 | 0.390 |
Why?
|
Attitude to Health | 4 | 2018 | 2020 | 0.390 |
Why?
|
Health Status Disparities | 5 | 2024 | 1880 | 0.390 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2418 | 0.390 |
Why?
|
Interinstitutional Relations | 2 | 2013 | 234 | 0.390 |
Why?
|
Vaginal Discharge | 1 | 2012 | 25 | 0.390 |
Why?
|
Pregnancy | 19 | 2023 | 30260 | 0.390 |
Why?
|
Social Environment | 2 | 2020 | 1011 | 0.390 |
Why?
|
Human Rights Abuses | 1 | 2012 | 34 | 0.390 |
Why?
|
Birth Intervals | 1 | 2012 | 54 | 0.380 |
Why?
|
Sex Distribution | 4 | 2021 | 2263 | 0.380 |
Why?
|
Minority Groups | 1 | 2019 | 1207 | 0.380 |
Why?
|
Health Facilities | 1 | 2017 | 577 | 0.380 |
Why?
|
Homosexuality, Male | 5 | 2022 | 1342 | 0.380 |
Why?
|
Checklist | 2 | 2018 | 848 | 0.380 |
Why?
|
General Surgery | 1 | 2023 | 1722 | 0.380 |
Why?
|
Research | 7 | 2021 | 1975 | 0.380 |
Why?
|
Surgical Procedures, Operative | 1 | 2023 | 1941 | 0.380 |
Why?
|
Risk Factors | 30 | 2024 | 74840 | 0.370 |
Why?
|
Curriculum | 3 | 2016 | 3782 | 0.370 |
Why?
|
Bereavement | 1 | 2015 | 308 | 0.370 |
Why?
|
Poverty | 6 | 2020 | 2714 | 0.370 |
Why?
|
Students | 1 | 2021 | 1734 | 0.370 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2020 | 2187 | 0.370 |
Why?
|
Psychotherapy, Group | 1 | 2015 | 416 | 0.370 |
Why?
|
Priapism | 1 | 2011 | 28 | 0.370 |
Why?
|
Maternal Health Services | 1 | 2017 | 472 | 0.370 |
Why?
|
HIV Seronegativity | 4 | 2021 | 209 | 0.360 |
Why?
|
Seafood | 1 | 2014 | 395 | 0.360 |
Why?
|
HIV Long-Term Survivors | 1 | 2011 | 140 | 0.360 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2017 | 1354 | 0.360 |
Why?
|
Alcoholism | 2 | 2020 | 1975 | 0.360 |
Why?
|
Delivery of Health Care | 4 | 2020 | 5370 | 0.360 |
Why?
|
Dibenzothiazepines | 1 | 2011 | 101 | 0.360 |
Why?
|
Psychometrics | 6 | 2021 | 3062 | 0.350 |
Why?
|
Odds Ratio | 10 | 2021 | 9649 | 0.350 |
Why?
|
Carotid Artery Diseases | 4 | 2021 | 874 | 0.350 |
Why?
|
Health Services Accessibility | 6 | 2021 | 5508 | 0.350 |
Why?
|
Goals | 2 | 2015 | 719 | 0.350 |
Why?
|
Aged | 40 | 2024 | 171117 | 0.350 |
Why?
|
Hunger | 1 | 2012 | 207 | 0.340 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 404 | 0.330 |
Why?
|
Glycerophospholipids | 1 | 2019 | 39 | 0.330 |
Why?
|
Tongue Diseases | 1 | 2010 | 70 | 0.330 |
Why?
|
Urinary Incontinence | 1 | 2014 | 491 | 0.330 |
Why?
|
Contraceptive Agents | 2 | 2021 | 147 | 0.330 |
Why?
|
India | 4 | 2020 | 2334 | 0.330 |
Why?
|
Developing Countries | 6 | 2025 | 2911 | 0.320 |
Why?
|
Editorial Policies | 2 | 2025 | 458 | 0.320 |
Why?
|
Educational Status | 2 | 2020 | 2513 | 0.310 |
Why?
|
Sexual Partners | 6 | 2021 | 804 | 0.310 |
Why?
|
Ethical Theory | 1 | 2008 | 34 | 0.310 |
Why?
|
Risk | 6 | 2021 | 9591 | 0.300 |
Why?
|
Research Personnel | 1 | 2013 | 590 | 0.300 |
Why?
|
Ethics, Pharmacy | 1 | 2008 | 6 | 0.300 |
Why?
|
Psychotherapy | 1 | 2017 | 1645 | 0.300 |
Why?
|
Environment Design | 1 | 2009 | 174 | 0.300 |
Why?
|
Prospective Studies | 25 | 2023 | 54802 | 0.290 |
Why?
|
Shame | 2 | 2019 | 80 | 0.290 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15880 | 0.290 |
Why?
|
Resilience, Psychological | 1 | 2015 | 806 | 0.280 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1188 | 0.280 |
Why?
|
Child | 22 | 2024 | 80564 | 0.280 |
Why?
|
Social Class | 2 | 2022 | 2007 | 0.280 |
Why?
|
Interviews as Topic | 8 | 2020 | 2739 | 0.270 |
Why?
|
Hypertension | 3 | 2024 | 8626 | 0.270 |
Why?
|
Commerce | 2 | 2002 | 611 | 0.270 |
Why?
|
Group Homes | 2 | 2024 | 58 | 0.270 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2019 | 291 | 0.270 |
Why?
|
Prenatal Diagnosis | 1 | 2014 | 1268 | 0.270 |
Why?
|
Combat Disorders | 1 | 2008 | 300 | 0.270 |
Why?
|
Benzoxazines | 2 | 2018 | 320 | 0.270 |
Why?
|
Health Resources | 2 | 2016 | 949 | 0.260 |
Why?
|
Chickens | 2 | 2020 | 842 | 0.260 |
Why?
|
Dystonia | 1 | 2010 | 376 | 0.260 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1882 | 0.260 |
Why?
|
Sex Offenses | 4 | 2016 | 356 | 0.260 |
Why?
|
Behavioral Risk Factor Surveillance System | 2 | 2018 | 212 | 0.260 |
Why?
|
Research Design | 6 | 2024 | 6209 | 0.260 |
Why?
|
Disabled Persons | 2 | 2024 | 1208 | 0.260 |
Why?
|
Caregivers | 4 | 2022 | 2307 | 0.250 |
Why?
|
Marketing | 1 | 2008 | 225 | 0.250 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5891 | 0.250 |
Why?
|
Cardiovascular Agents | 1 | 2011 | 851 | 0.240 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2018 | 6014 | 0.240 |
Why?
|
Medicaid | 2 | 2017 | 2833 | 0.240 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2014 | 1396 | 0.230 |
Why?
|
Residence Characteristics | 6 | 2018 | 2116 | 0.230 |
Why?
|
Suicide, Attempted | 1 | 2013 | 1409 | 0.230 |
Why?
|
Factor Analysis, Statistical | 4 | 2021 | 999 | 0.220 |
Why?
|
Water Purification | 1 | 2024 | 61 | 0.220 |
Why?
|
Lighting | 2 | 2023 | 211 | 0.220 |
Why?
|
Alzheimer Disease | 2 | 2020 | 8730 | 0.220 |
Why?
|
Treatment Outcome | 16 | 2019 | 65188 | 0.220 |
Why?
|
Legislation as Topic | 1 | 2003 | 76 | 0.210 |
Why?
|
Solar Energy | 1 | 2023 | 8 | 0.210 |
Why?
|
Smoking | 2 | 2022 | 9081 | 0.210 |
Why?
|
Religion and Psychology | 2 | 2016 | 179 | 0.210 |
Why?
|
Proportional Hazards Models | 7 | 2024 | 12509 | 0.210 |
Why?
|
Military Personnel | 2 | 2012 | 1252 | 0.210 |
Why?
|
Industry | 1 | 2005 | 362 | 0.210 |
Why?
|
Gift Giving | 1 | 2003 | 76 | 0.210 |
Why?
|
Schools, Medical | 1 | 2009 | 876 | 0.200 |
Why?
|
Thiazoles | 1 | 2010 | 1529 | 0.200 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12056 | 0.200 |
Why?
|
Postal Service | 1 | 2002 | 96 | 0.200 |
Why?
|
Mosquito Control | 2 | 2022 | 110 | 0.200 |
Why?
|
Persuasive Communication | 1 | 2002 | 58 | 0.200 |
Why?
|
Anthrax | 1 | 2002 | 83 | 0.200 |
Why?
|
Catha | 1 | 2021 | 9 | 0.200 |
Why?
|
Drug Prescriptions | 2 | 2009 | 1662 | 0.190 |
Why?
|
Logistic Models | 7 | 2022 | 13266 | 0.190 |
Why?
|
Sex Factors | 10 | 2019 | 10603 | 0.190 |
Why?
|
Chemoprevention | 2 | 2014 | 327 | 0.190 |
Why?
|
Patient Compliance | 5 | 2017 | 2692 | 0.190 |
Why?
|
Basic Reproduction Number | 1 | 2021 | 38 | 0.190 |
Why?
|
Kenya | 3 | 2024 | 758 | 0.190 |
Why?
|
Deception | 1 | 2002 | 99 | 0.190 |
Why?
|
Health Priorities | 3 | 2009 | 382 | 0.190 |
Why?
|
Child, Preschool | 10 | 2024 | 42500 | 0.190 |
Why?
|
Cardiovascular Diseases | 6 | 2022 | 15652 | 0.190 |
Why?
|
District of Columbia | 1 | 2021 | 159 | 0.190 |
Why?
|
Program Development | 3 | 2013 | 1295 | 0.180 |
Why?
|
Africa, Northern | 1 | 2021 | 85 | 0.180 |
Why?
|
Publishing | 2 | 2025 | 835 | 0.180 |
Why?
|
Drug Resistance | 2 | 2022 | 1591 | 0.180 |
Why?
|
Family Planning Services | 2 | 2021 | 278 | 0.180 |
Why?
|
Guidelines as Topic | 3 | 2008 | 1394 | 0.180 |
Why?
|
Antiviral Agents | 2 | 2015 | 3050 | 0.180 |
Why?
|
Lung Diseases, Obstructive | 1 | 2022 | 309 | 0.180 |
Why?
|
Education, Graduate | 1 | 2021 | 75 | 0.180 |
Why?
|
Bronchial Spasm | 1 | 2021 | 71 | 0.180 |
Why?
|
Contraception | 2 | 2021 | 361 | 0.180 |
Why?
|
Ciprofloxacin | 1 | 2002 | 314 | 0.180 |
Why?
|
Program Evaluation | 3 | 2013 | 2499 | 0.180 |
Why?
|
Referral and Consultation | 1 | 2013 | 3615 | 0.170 |
Why?
|
Obesity | 3 | 2021 | 13076 | 0.170 |
Why?
|
Crowding | 1 | 2021 | 142 | 0.170 |
Why?
|
International Cooperation | 2 | 2018 | 1432 | 0.170 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 281 | 0.170 |
Why?
|
Models, Statistical | 2 | 2014 | 5089 | 0.170 |
Why?
|
Poverty Areas | 2 | 2014 | 268 | 0.170 |
Why?
|
Education, Medical, Undergraduate | 1 | 2009 | 1085 | 0.170 |
Why?
|
Renin-Angiotensin System | 1 | 2024 | 737 | 0.170 |
Why?
|
Mosquito Nets | 1 | 2019 | 8 | 0.160 |
Why?
|
Aged, 80 and over | 8 | 2022 | 59489 | 0.160 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.160 |
Why?
|
Birth Rate | 1 | 2020 | 169 | 0.160 |
Why?
|
Attitude | 1 | 2024 | 770 | 0.160 |
Why?
|
Sierra Leone | 2 | 2017 | 171 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 219 | 0.160 |
Why?
|
Viremia | 2 | 2021 | 727 | 0.160 |
Why?
|
Incidence | 6 | 2021 | 21480 | 0.160 |
Why?
|
Diet | 2 | 2014 | 8086 | 0.150 |
Why?
|
Case-Control Studies | 9 | 2022 | 22223 | 0.150 |
Why?
|
Interleukin-6 | 5 | 2019 | 3222 | 0.150 |
Why?
|
Language | 2 | 2022 | 1550 | 0.150 |
Why?
|
Urban Health | 1 | 2021 | 530 | 0.150 |
Why?
|
Colectomy | 1 | 2023 | 697 | 0.150 |
Why?
|
Religion and Medicine | 1 | 2019 | 162 | 0.150 |
Why?
|
Nepal | 2 | 2019 | 301 | 0.140 |
Why?
|
Gynecology | 2 | 2014 | 535 | 0.140 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2024 | 1061 | 0.140 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1514 | 0.140 |
Why?
|
Security Measures | 1 | 2018 | 83 | 0.140 |
Why?
|
Women's Health | 2 | 2019 | 2084 | 0.140 |
Why?
|
Communication | 2 | 2022 | 3916 | 0.140 |
Why?
|
Physicians | 3 | 2012 | 4588 | 0.140 |
Why?
|
Decision Support Techniques | 2 | 2018 | 2003 | 0.140 |
Why?
|
Scientific Misconduct | 2 | 2025 | 77 | 0.140 |
Why?
|
Nevirapine | 1 | 2018 | 273 | 0.140 |
Why?
|
Fasting | 2 | 2020 | 1606 | 0.140 |
Why?
|
Chronic Disease | 4 | 2019 | 9347 | 0.140 |
Why?
|
Obstetrics | 2 | 2014 | 680 | 0.130 |
Why?
|
Emergencies | 1 | 2023 | 1223 | 0.130 |
Why?
|
Drug Users | 1 | 2018 | 134 | 0.130 |
Why?
|
AIDS Serodiagnosis | 1 | 2018 | 220 | 0.130 |
Why?
|
Feasibility Studies | 4 | 2020 | 5302 | 0.130 |
Why?
|
Treatment Failure | 1 | 2022 | 2652 | 0.130 |
Why?
|
Comorbidity | 5 | 2019 | 10563 | 0.130 |
Why?
|
Longevity | 1 | 2024 | 1087 | 0.130 |
Why?
|
Risk Assessment | 8 | 2021 | 24282 | 0.130 |
Why?
|
Spirometry | 4 | 2022 | 929 | 0.130 |
Why?
|
Respiration Disorders | 1 | 2019 | 362 | 0.130 |
Why?
|
Hepacivirus | 1 | 2023 | 1343 | 0.130 |
Why?
|
Carbon Monoxide | 1 | 2019 | 560 | 0.130 |
Why?
|
Neoplasms | 2 | 2021 | 22340 | 0.130 |
Why?
|
American Medical Association | 2 | 2008 | 60 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 586 | 0.120 |
Why?
|
Malnutrition | 2 | 2012 | 629 | 0.120 |
Why?
|
Eggs | 1 | 2016 | 182 | 0.120 |
Why?
|
Developmental Disabilities | 1 | 2024 | 1519 | 0.120 |
Why?
|
Nutritional Status | 3 | 2012 | 1620 | 0.120 |
Why?
|
Telemedicine | 1 | 2013 | 3105 | 0.120 |
Why?
|
Periodicals as Topic | 2 | 2025 | 1462 | 0.120 |
Why?
|
Forced Expiratory Volume | 4 | 2022 | 1828 | 0.120 |
Why?
|
Health Services Research | 3 | 2013 | 1808 | 0.120 |
Why?
|
Interview, Psychological | 1 | 2018 | 812 | 0.120 |
Why?
|
Anti-Infective Agents | 1 | 2002 | 986 | 0.120 |
Why?
|
Electroencephalography | 1 | 2010 | 6273 | 0.120 |
Why?
|
C-Reactive Protein | 4 | 2019 | 3850 | 0.120 |
Why?
|
Madagascar | 3 | 2021 | 111 | 0.120 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 368 | 0.120 |
Why?
|
United Nations | 1 | 2015 | 151 | 0.120 |
Why?
|
Child Welfare | 2 | 2008 | 521 | 0.110 |
Why?
|
Mental Status Schedule | 1 | 2015 | 315 | 0.110 |
Why?
|
Economic Recession | 1 | 2015 | 79 | 0.110 |
Why?
|
Air Pollution, Indoor | 1 | 2022 | 931 | 0.110 |
Why?
|
HIV Antibodies | 1 | 2021 | 1337 | 0.110 |
Why?
|
Long QT Syndrome | 1 | 2018 | 474 | 0.110 |
Why?
|
Urban Population | 4 | 2021 | 2040 | 0.110 |
Why?
|
Bipolar Disorder | 1 | 2011 | 5138 | 0.110 |
Why?
|
Consensus | 2 | 2024 | 3202 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2019 | 744 | 0.110 |
Why?
|
Maternal Mortality | 1 | 2017 | 313 | 0.110 |
Why?
|
Public Health | 3 | 2016 | 2680 | 0.110 |
Why?
|
Infant | 5 | 2024 | 36386 | 0.110 |
Why?
|
Helminthiasis | 1 | 2014 | 81 | 0.110 |
Why?
|
Soil | 1 | 2014 | 123 | 0.110 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 3247 | 0.110 |
Why?
|
HIV-1 | 5 | 2019 | 6944 | 0.110 |
Why?
|
Fear | 1 | 2022 | 1499 | 0.110 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 531 | 0.110 |
Why?
|
Monitoring, Ambulatory | 1 | 2017 | 357 | 0.110 |
Why?
|
Kynurenine | 1 | 2014 | 142 | 0.110 |
Why?
|
Forecasting | 2 | 2020 | 2936 | 0.110 |
Why?
|
Recurrence | 2 | 2019 | 8501 | 0.110 |
Why?
|
Pilot Projects | 2 | 2017 | 8733 | 0.110 |
Why?
|
Data Collection | 2 | 2015 | 3318 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2022 | 3424 | 0.110 |
Why?
|
New York City | 1 | 2015 | 733 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2844 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 622 | 0.100 |
Why?
|
Psychotic Disorders | 1 | 2008 | 3270 | 0.100 |
Why?
|
Disease Outbreaks | 1 | 2002 | 1759 | 0.100 |
Why?
|
Focus Groups | 1 | 2019 | 1459 | 0.100 |
Why?
|
Medicine, African Traditional | 1 | 2013 | 31 | 0.100 |
Why?
|
Health Services | 2 | 2016 | 756 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2020 | 1069 | 0.100 |
Why?
|
Time Factors | 9 | 2021 | 40065 | 0.100 |
Why?
|
Theft | 1 | 2012 | 20 | 0.100 |
Why?
|
Hospitals | 1 | 2006 | 3888 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2018 | 718 | 0.100 |
Why?
|
Publication Bias | 1 | 2013 | 158 | 0.100 |
Why?
|
Sudan | 1 | 2012 | 86 | 0.100 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2817 | 0.100 |
Why?
|
Continuity of Patient Care | 2 | 2022 | 1078 | 0.100 |
Why?
|
Linear Models | 3 | 2017 | 5876 | 0.100 |
Why?
|
Confidentiality | 1 | 2016 | 607 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2022 | 39193 | 0.100 |
Why?
|
Tryptophan | 1 | 2014 | 483 | 0.100 |
Why?
|
Insecticides | 1 | 2013 | 203 | 0.100 |
Why?
|
Hospital Mortality | 1 | 2006 | 5343 | 0.100 |
Why?
|
Puerperal Disorders | 1 | 2014 | 306 | 0.100 |
Why?
|
Leadership | 1 | 2021 | 1392 | 0.090 |
Why?
|
Healthcare Disparities | 3 | 2024 | 3413 | 0.090 |
Why?
|
Internet | 2 | 2009 | 3106 | 0.090 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6544 | 0.090 |
Why?
|
Carotid Arteries | 3 | 2022 | 929 | 0.090 |
Why?
|
Lung | 2 | 2022 | 10033 | 0.090 |
Why?
|
Torture | 1 | 2012 | 68 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2018 | 4405 | 0.090 |
Why?
|
Safe Sex | 1 | 2012 | 144 | 0.090 |
Why?
|
Africa | 1 | 2014 | 725 | 0.090 |
Why?
|
Coitus | 1 | 2012 | 133 | 0.090 |
Why?
|
Sleep | 2 | 2024 | 4813 | 0.090 |
Why?
|
Electrocardiography | 3 | 2019 | 6404 | 0.090 |
Why?
|
Self Concept | 2 | 2018 | 1037 | 0.090 |
Why?
|
Botswana | 2 | 2012 | 1057 | 0.090 |
Why?
|
Inflammation | 3 | 2019 | 10850 | 0.090 |
Why?
|
Government | 1 | 2012 | 161 | 0.090 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 838 | 0.090 |
Why?
|
Sick Leave | 1 | 2012 | 105 | 0.090 |
Why?
|
Antigens, CD | 2 | 2018 | 4025 | 0.090 |
Why?
|
Geographic Information Systems | 1 | 2013 | 280 | 0.090 |
Why?
|
Fishes | 1 | 2014 | 606 | 0.090 |
Why?
|
Retrospective Studies | 8 | 2024 | 81514 | 0.090 |
Why?
|
Crime | 1 | 2012 | 206 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2393 | 0.090 |
Why?
|
ROC Curve | 2 | 2019 | 3620 | 0.090 |
Why?
|
Syndrome | 1 | 2017 | 3271 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 824 | 0.090 |
Why?
|
Phenylephrine | 1 | 2011 | 292 | 0.090 |
Why?
|
Restraint, Physical | 1 | 2012 | 186 | 0.090 |
Why?
|
Quality of Health Care | 1 | 2005 | 4300 | 0.090 |
Why?
|
Health Expenditures | 1 | 2003 | 2387 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2021 | 1529 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2023 | 3000 | 0.080 |
Why?
|
Psychoanalytic Therapy | 1 | 2012 | 219 | 0.080 |
Why?
|
Arabs | 1 | 2012 | 190 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1640 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2014 | 798 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2047 | 0.080 |
Why?
|
Coronary Disease | 1 | 2024 | 5912 | 0.080 |
Why?
|
Probability | 1 | 2015 | 2475 | 0.080 |
Why?
|
Self Care | 1 | 2015 | 800 | 0.080 |
Why?
|
Hospitalization | 2 | 2024 | 10808 | 0.080 |
Why?
|
RNA, Viral | 2 | 2015 | 2864 | 0.080 |
Why?
|
Rural Health Services | 2 | 2013 | 393 | 0.080 |
Why?
|
Contraception Behavior | 2 | 2021 | 185 | 0.080 |
Why?
|
Social Perception | 1 | 2013 | 436 | 0.080 |
Why?
|
Ohio | 2 | 2008 | 320 | 0.080 |
Why?
|
Attitude to Death | 1 | 2012 | 399 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1187 | 0.080 |
Why?
|
Micronutrients | 1 | 2011 | 390 | 0.080 |
Why?
|
Thinness | 1 | 2012 | 482 | 0.080 |
Why?
|
Contact Tracing | 2 | 2021 | 274 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 8067 | 0.080 |
Why?
|
Morbidity | 3 | 2020 | 1749 | 0.080 |
Why?
|
Ethicists | 1 | 2008 | 39 | 0.080 |
Why?
|
Social Behavior | 1 | 2015 | 1146 | 0.070 |
Why?
|
Health Care Reform | 1 | 2017 | 1259 | 0.070 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2012 | 664 | 0.070 |
Why?
|
Environmental Exposure | 2 | 2022 | 4544 | 0.070 |
Why?
|
Physical Fitness | 1 | 2012 | 742 | 0.070 |
Why?
|
Empirical Research | 1 | 2008 | 119 | 0.070 |
Why?
|
Vital Capacity | 2 | 2022 | 995 | 0.070 |
Why?
|
Lithium | 1 | 2011 | 597 | 0.070 |
Why?
|
Air Pollution | 1 | 2022 | 2380 | 0.070 |
Why?
|
England | 1 | 2009 | 533 | 0.070 |
Why?
|
Brazil | 1 | 2012 | 1248 | 0.070 |
Why?
|
Air Pollutants | 1 | 2022 | 2923 | 0.070 |
Why?
|
Blood Glucose | 2 | 2019 | 6424 | 0.070 |
Why?
|
Alkynes | 2 | 2018 | 326 | 0.070 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2019 | 428 | 0.070 |
Why?
|
Bioethical Issues | 1 | 2008 | 119 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2013 | 496 | 0.070 |
Why?
|
Heart Rate | 1 | 2018 | 4204 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10383 | 0.070 |
Why?
|
Cyclopropanes | 2 | 2018 | 437 | 0.070 |
Why?
|
Medical Records | 1 | 2012 | 1409 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2821 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2084 | 0.070 |
Why?
|
Adolescent Behavior | 1 | 2015 | 1185 | 0.070 |
Why?
|
Patient Dropouts | 1 | 2008 | 410 | 0.060 |
Why?
|
Massachusetts | 3 | 2024 | 8875 | 0.060 |
Why?
|
Reward | 1 | 2013 | 981 | 0.060 |
Why?
|
Physical Examination | 1 | 2012 | 1266 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1509 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2024 | 1811 | 0.060 |
Why?
|
Documentation | 1 | 2012 | 916 | 0.060 |
Why?
|
Respiratory Function Tests | 2 | 2022 | 1693 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2019 | 3985 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2022 | 26346 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1472 | 0.060 |
Why?
|
Harm Reduction | 2 | 2018 | 141 | 0.060 |
Why?
|
Firearms | 1 | 2012 | 630 | 0.060 |
Why?
|
Vermont | 1 | 2003 | 80 | 0.050 |
Why?
|
Blood Pressure | 1 | 2019 | 8532 | 0.050 |
Why?
|
Quality-Adjusted Life Years | 2 | 2020 | 1737 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2003 | 7875 | 0.050 |
Why?
|
Droughts | 1 | 2022 | 27 | 0.050 |
Why?
|
Los Angeles | 1 | 2003 | 244 | 0.050 |
Why?
|
Diarrhea | 1 | 2009 | 1316 | 0.050 |
Why?
|
Heart Failure | 1 | 2006 | 11840 | 0.050 |
Why?
|
Insurance Coverage | 2 | 2023 | 1944 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9747 | 0.050 |
Why?
|
Parents | 1 | 2015 | 3592 | 0.050 |
Why?
|
Human Growth Hormone | 1 | 2005 | 638 | 0.040 |
Why?
|
Men | 1 | 2021 | 65 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2009 | 1387 | 0.040 |
Why?
|
Motivation | 1 | 2020 | 2018 | 0.040 |
Why?
|
State Government | 1 | 2003 | 388 | 0.040 |
Why?
|
Republic of Korea | 1 | 2022 | 588 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2012 | 3212 | 0.040 |
Why?
|
Nebulizers and Vaporizers | 1 | 2021 | 138 | 0.040 |
Why?
|
Cooking | 1 | 2022 | 327 | 0.040 |
Why?
|
Censuses | 1 | 2020 | 197 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5189 | 0.040 |
Why?
|
Parity | 1 | 2022 | 931 | 0.040 |
Why?
|
Religion | 1 | 2022 | 376 | 0.040 |
Why?
|
National Health Programs | 1 | 2022 | 443 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 786 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2022 | 423 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6309 | 0.040 |
Why?
|
Nigeria | 1 | 2022 | 782 | 0.040 |
Why?
|
Government Regulation | 1 | 2003 | 525 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2010 | 1938 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12240 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3925 | 0.040 |
Why?
|
Limit of Detection | 1 | 2018 | 272 | 0.040 |
Why?
|
Medically Uninsured | 1 | 2003 | 838 | 0.040 |
Why?
|
World Health Organization | 2 | 2017 | 1328 | 0.030 |
Why?
|
Decision Making | 2 | 2013 | 3965 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2021 | 2778 | 0.030 |
Why?
|
Ethnopsychology | 1 | 2016 | 19 | 0.030 |
Why?
|
Nursing Homes | 1 | 2023 | 1084 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 766 | 0.030 |
Why?
|
Animals | 3 | 2020 | 168764 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2021 | 1141 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 552 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 647 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1595 | 0.030 |
Why?
|
Body Mass Index | 3 | 2019 | 13039 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2019 | 580 | 0.030 |
Why?
|
Age Factors | 3 | 2019 | 18380 | 0.030 |
Why?
|
Social Values | 1 | 2016 | 224 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2033 | 0.030 |
Why?
|
Biostatistics | 1 | 2016 | 162 | 0.030 |
Why?
|
Demography | 1 | 2019 | 1641 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2003 | 1672 | 0.030 |
Why?
|
Community-Based Participatory Research | 1 | 2016 | 224 | 0.030 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2014 | 120 | 0.030 |
Why?
|
Social Responsibility | 1 | 2016 | 382 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2415 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2019 | 3564 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2441 | 0.020 |
Why?
|
Child Development | 1 | 2023 | 2327 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4850 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15398 | 0.020 |
Why?
|
Plasma | 1 | 2014 | 579 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 433 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 951 | 0.020 |
Why?
|
Mentors | 1 | 2016 | 671 | 0.020 |
Why?
|
Particulate Matter | 1 | 2022 | 2624 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2352 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1805 | 0.020 |
Why?
|
Diarrhea, Infantile | 1 | 2009 | 100 | 0.020 |
Why?
|
Infant Welfare | 1 | 2009 | 78 | 0.020 |
Why?
|
Causality | 1 | 2014 | 1248 | 0.020 |
Why?
|
Teaching | 1 | 2016 | 1169 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3315 | 0.020 |
Why?
|
Administrative Personnel | 1 | 2009 | 186 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 8041 | 0.020 |
Why?
|
Faculty, Medical | 1 | 2016 | 1219 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3926 | 0.020 |
Why?
|
Investments | 1 | 2009 | 148 | 0.020 |
Why?
|
Infant Care | 1 | 2009 | 181 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3236 | 0.020 |
Why?
|
Travel | 1 | 2013 | 806 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10070 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5993 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7049 | 0.020 |
Why?
|
Immunity | 1 | 2011 | 1002 | 0.020 |
Why?
|
Aging | 1 | 2024 | 8731 | 0.020 |
Why?
|
Age Determination by Skeleton | 1 | 2005 | 124 | 0.020 |
Why?
|
Medicare | 1 | 2003 | 6823 | 0.010 |
Why?
|
Prescription Fees | 1 | 2005 | 153 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13632 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13024 | 0.010 |
Why?
|
Community Health Services | 1 | 2009 | 657 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14652 | 0.010 |
Why?
|
Child Health Services | 1 | 2009 | 645 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4863 | 0.010 |
Why?
|
Drug Utilization | 1 | 2005 | 1187 | 0.010 |
Why?
|
Endocrinology | 1 | 2005 | 444 | 0.010 |
Why?
|
Body Height | 1 | 2005 | 1562 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29922 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16047 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5526 | 0.010 |
Why?
|
Primary Health Care | 1 | 2013 | 4736 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6493 | 0.010 |
Why?
|
Pediatrics | 1 | 2005 | 3606 | 0.010 |
Why?
|